Timothy B Lowinger insider trades

Open-market stock purchases and sales by Timothy B Lowinger, SVP, Chief Sci.&Tech. Officer at Mersana Therapeutics, Inc, from SEC Form 4 filings since Feb 2, 2018.

Recent trades

DateStockTradeValue
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$48.8K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$107K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$248K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$561K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$62.6K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$36.8K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$142K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$476K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$145K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$130K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$892K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$78.5K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$601K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$188K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$2.6M
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$33.8K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$508K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—

Companies traded

  • MRSN Mersana Therapeutics, Inc: 44 sales, last Jan 6, 2026
  • [MRSN] Mersana Therapeutics, Inc: other filings, last Dec 28, 2020

Get free alerts when Timothy B Lowinger files a new trade →